The three most active stocks and funds in pre-market trading on the Nasdaq were Human Genome Sciences (HGSI) Gilead Sciences (GILD) and PowerShares QQQ (QQQ) as of 9:10 a.m. Investors traded 15 547 055 shares of Human Genome Sciences which was up $7.28 or 101.53%. Human Genome Sciences rejected an unsolicited $2.59 billion buyout offer from GlaxoSmithKline plc (GSK). Human Genome Sciences cited that the offer of $13 per share undervalues its company.
The three most active stocks and funds in pre-market trading on the Nasdaq were Riverbed Technology (RVBD) Sirius XM Radio (SIRI) and PowerShares QQQ (QQQ) as of 9:00 a.m. Investors traded 2 927 460 shares of Riverbed Technology whi... Read Post
MINYANVILLE ORIGINAL The three most active funds and stocks in pre-market trading on the Nasdaq were PowerShares QQQ Trust (QQQ) Gen-Probe Incorporated (GPRO) and Hologic Incorporated (HOLX) as of 9:00 a.m. Investors traded 1 568 14... Read Post
By Jason Russ: Short sellers of Gilead Sciences (NASDAQ:GILD) must be starting to sweat a bit as the stock continues its impressive trajectory: GILD data by YCharts Right along with the rising share price, the shorts have been pilin... Read Post